Announcements Trials
Browse Landscape

Status

Completed 64Terminated 14Unknown 8Withdrawn 6Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Chromosome Aberrations 1Carcinogenesis 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00280202 2025-10-24

Detection of Genetic Markers of Lung Cancer

University of Pittsburgh

Recruiting
6,000 enrolled
Thoracic

Chromosome Aberrations, Lung Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡